IMCAS Academy

Introduction
Program
Speakers
Sponsor list
Accreditation

IMCAS Asia 2019
Program

FOCUS ON S057

Clinical dermatology - Inflammatory disease

Room: Room 3A
Date: Saturday 6 July 2019 at 08:30 to 09:30
Format: FOCUS SESSION > lectures covering a major topic of the congress
Objectives: 1. Evaluate present and future therapies for dermatologic conditions and acne 2. Recognize and correctly diagnose inflammatory skin diseases 3. Discuss the effects psychological state of patient has on skin

Chairs

Dr Victor Gabriel CLATICI

Dermatologist

Romania

Dr Anak Agung Gde PUTRA WIRAGUNA

Dermatologist

Indonesia

Lectures of the session

Hours	Speakers	Lecture title	Abstract	Number
08:30	Dr Yuan Li Grace LIAO	SOS (Skin optimization solutions) theory to improve patients' skin condition	View	85732
08:42	Dr Pin Chi CHIU	Common mistakes in atopic dermatitis skin care	View	85272
08:54	Prof Tokuya OMI	Acne treatment in clinical dermatology and aesthetic dermatology	View	70623
09:06	Dr Nyoman SURYAWATI	Combination treatment of narrowband ultraviolet B, low dose zinc oral and topical corticosteroid cream in management of guttate psoriasis: a case report		94946
09:18		Questions and answers		88184

Go to previous room (Room 2)

Go to next session

Recommended sessions

Eczema / atopic dermatitis

Cosmeceuticals

Psoriasis

Skin diseases

Lasers

Dr Yuan Li Grace LIAO

Dermatologist

Taiwan

Other author(s) : Dr. Grace Yuan-li Liao

SOS (Skin optimization solutions) theory to improve patients' skin condition

Objectives: To remind the importance of skin preventive medicine.

Introduction: Skin problems has resulted in the leading 4th Global burden. But actually lots of skin diseases are preventable, esp eczematous skin diseases.

Materials / method: Review of papers and 20-year clinical experiences sharing.

Results: If we can make skin barrier function better, we can prevent a large amount of skin disorders.

Conclusion: Dermatologists have the responsibility to deliver the preventive skin medicine to patients. Through correct daily skin care, the skin can be kept in a healthy status.

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work was not supported by any direct or non direct funding. It is under the author's own responsability

Dr Pin Chi CHIU

Dermatologist

Taiwan

Other author(s) :

Common mistakes in atopic dermatitis skin care

Objectives: Learn more details about common mistakes in atopic dermatitis skin care

Introduction: Atopic dermatitis(AD) is the most common chronic inflammatory skin disease with substantial effects on quality of life. AD is characterized by intense itch, recurrent eczematous lesions and a fluctuating course. AD has a strong heritability component and is closely related to and commonly co-occurs with other atopic diseases (such as asthma and allergic rhinitis). Several pathophysiological mechanisms contribute to AD etiology and clinical manifestations.

Results: Moisturizer application is a mainstay in the treatment of atopic dermatitis, irrespective of disease severity and current disease activity. Consistent application of moisturizers plays a key role in restoring skin barrier function and reducing xerosis as well as pruritus.

Conclusion: In this speech, I will highlight some common errors and misconceptions in AD skin care from four aspects. All these information are clinically relevant and useful.

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work was not supported by any direct or non direct funding. It is under the author's own responsability

Prof Tokuya OMI

Dermatologist

Japan

Other author(s) :

Acne treatment in clinical dermatology and aesthetic dermatology

Objectives: Acne treatment in clinical and aesthetic dermatology

Acne vulgaris is a common skin disease that is said to affect more than 90% of Japanese adolescents. Treatment guidelines have been established in Western countries and also in Japan, and generalized treatment of acne is recommended for mild to severe cases.
Benzoyl peroxide (BPO) and adapalene are currently being used for topical treatment in mild cases, and oral antibiotics are recommended for moderate cases. However, antimicrobial-resistant acne has become a problem when antibiotics are used, and cosmetic treatment by means of chemical p

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work was not supported by any direct or non direct funding. It is under the author's own responsability

Dr Nyoman SURYAWATI

Dermatologist

Indonesia

Other author(s) :

Combination treatment of narrowband ultraviolet B, low dose zinc oral and topical corticosteroid cream in management of guttate psoriasis: a case report

Objectives: Reporting a case of GP patient with a combination treatment of Narrowband Ultraviolet B (NB-UVB), a low dose of oral zinc, and topical corticosteroid

Introduction: Guttate psoriasis (GP) is a distinctive acute form of psoriasis, more frequent in children and young adults. There were several combination treatments in GP, such as methotrexate (MTX) and ultraviolet B (UVB); MTX and psoralen ultraviolet A (PUVA); also UVB and PUVA. Some investigators have correlated zinc levels with the extent of skin lesion.

Materials / method: A-21 years-old Balinese man, skin phototype IV, presented a pruritic, erythematous rash since two weeks ago. He felt swallowing pain before the rash appeared. He had the same skin rash since nine years ago, but there was no history of skin disease or allergy in his family. Physical examination on the chest, back, upper, and lower extremities showed multiple erythematous papules, covered with thin white scales on 20% of body surface area (BSA). Psoriasis Area and Severity Index (PASI) score was 12.3.

Results: There were no abnormalities in laboratory examination; including. Zinc and Anti-Streptolysin O serum levels Throat swab found a commensal bacteria. Dermoscopic examination showed diffuse red dotted vessels. The histopathologic result supported GP. He showed PASI score reduction (6.9) after treatment with three-times NB-UVB, zinc tablet 20 mg daily, and desoximetasone 0.25% cream twice daily.

Conclusion: Guarino et al. (2016), reported that 78% of GP patients achieving PASI90 in a mean of 19.9 sessions with maintained response during 18 months without NB-UVB treatment. In this case, the patient was treated with combination NB-UVB, a low dose of oral zinc and corticosteroid cream and showed a reduction of PASI score of 43.9%. This combination treatment can be a treatment modality for GP due to its good response with minimal side effects

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work was not supported by any direct or non direct funding. It is under the author's own responsability

Questions and answers

You have a question?

Quickly find your answer in our FAQ

Congresses

IMCAS Americas
IMCAS Asia
IMCAS World Congress

About

Company
Privacy Policy
Legal information

Academy

Home
Courses
Webinars
Explore
Blog

Grant

Educational grant

Get in touch

Username/Email

Password

Keep me logged in

Forgot password ? Do not have an account yet? Sign up now

Keep me logged in

academy.Do_not_have_an_account_yet Sign up now

IMCAS Asia 2019 Program

FOCUS ON S057

Clinical dermatology - Inflammatory disease

Chairs

Lectures of the session

Recommended sessions

IMCAS Asia 2019
Program